Literature DB >> 2157333

Three sensitive methods for the detection of cytomegalovirus in lung tissue of patients with interstitial pneumonitis.

M Jiwa1, R D Steenbergen, F E Zwaan, P M Kluin, A K Raap, M van der Ploeg.   

Abstract

Interstitial pneumonia after allogeneic bone marrow transplantation is frequently associated with human cytomegalovirus (HCMV) infection. However, in a considerable proportion of the cases, no infectious agent can be determined and the interstitial pneumonia is then classified as idiopathic. Hypothetically, idiopathic interstitial pneumonia could be caused by HCMV present in such small amounts or such conformation that the virus cannot be detected by routine histopathologic analysis or viral culture techniques. To check this hypothesis, three sensitive methods for HCMV detection (in situ hybridization, the polymerase chain reaction for HCMV-DNA detection, and immunohistochemistry for the detection of HCMV immediate early antigens) have been applied on lung tissue sections of bone marrow transplant patients who died with interstitial pneumonia. Three categories were distinguished: (1) patients with HCMV-related interstitial pneumonia (n = 5); (2) patients with idiopathic interstitial pneumonia (n = 10); and (3) patients with HCMV interstitial pneumonia who had been treated with antiviral therapy (n = 2). In the first category, all three techniques yielded clearly positive results, whereas these techniques indicated that one of the patients of the second category had HCMV-related pneumonia. In the third category no positive signals could be obtained. The presented data indicate that a direct involvement of HCMV in idiopathic interstitial pneumonia is unlikely. However, a PCR performed for Epstein-Barr virus (EBV) was positive in two patients with idiopathic interstitial pneumonia. These data indicate that the introduction of new sensitive techniques such as in situ hybridization, immunohistochemistry, and the polymerase chain reaction revives the interest for HCMV and other causative infectious agents in idiopathic interstitial pneumonia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157333     DOI: 10.1093/ajcp/93.4.491

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Simian virus 40 large T-antigen, but not small T-antigen, trans-activates the human cytomegalovirus major immediate early promoter.

Authors:  U Moens; M Van Ghelue; A K Kristoffersen; B Johansen; O P Rekvig; M Degré; H Rollag
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

2.  Comparison of different methods for CMV detection.

Authors:  T Bajanowski; P Wiegand; B Brinkmann
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

3.  Conserved CDR 3 region of T cell receptor BV gene in lymphocytes from bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis.

Authors:  N Shimizudani; H Murata; H Keino; S Kojo; H Nakamura; Y Morishima; T Sakamoto; M Ohtsuka; K Sekisawa; M Sumida; T Sumida; T Matsuoka
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

4.  An improved technique for the diagnosis of viral retinitis from samples of aqueous humor and vitreous.

Authors:  J Garweg; T Fenner; M Böhnke; H Schmitz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-09       Impact factor: 3.117

5.  CMV-DNA detection in parenchymatous organs in cases of SIDS.

Authors:  R Cecchi; T Bajanowski; B Kahl; P Wiegand
Journal:  Int J Legal Med       Date:  1995       Impact factor: 2.686

6.  Correlation of interstitial pneumonia with human cytomegalovirus-induced lung infection and graft-versus-host disease after bone marrow transplantation.

Authors:  C A Müller; H Hebart; A Roos; H Roos; M Steidle; H Einsele
Journal:  Med Microbiol Immunol       Date:  1995-10       Impact factor: 3.402

Review 7.  Pulmonary fibrosis.

Authors:  David A Zisman; Michael P Keane; John A Belperio; Robert M Strieter; Joseph P Lynch
Journal:  Methods Mol Med       Date:  2005
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.